LifePoint Health Reports Fourth Quarter and Year-End 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Cantor Fitzgerald Reiterates Neutral on LifePoint Health (LPNT) After Adjusting Estimates
February 21, 2017 7:00 AM ESTCantor Fitzgerald reiterated a Neutral rating and $55.00 price target on LifePoint Health (NASDAQ: LPNT) after adjusting estimates. Cantor raised full year 2017 adjusted EPS estimates to $4.10 from $4.00, vs. the $4.13 consensus and the $4.05-$4.34 guidance. Cantor also raised adjusted EBITDA to $778 million (from $745 million) vs. the $803... More
LifePoint Health (LPNT) Tops Q4 EPS by 1c
February 17, 2017 7:06 AM ESTLifePoint Health (NASDAQ: LPNT) reported Q4 EPS of $1.09, $0.01 better than the analyst estimate of $1.08. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.63 billion.
GUIDANCE:
LifePoint Health sees FY2017 revenue of $6.5-6.6 billion, versus the consensus of... More
